All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Restenosis Coronary angiography · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower restenosis Coronary angiography compared with conventional western medicine (CWM) plus placebo (high certainty).
1 finding from 1 review
Recurrence angina pectoris with 1 month · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower recurrence angina pectoris with 1 month compared with conventional western medicine (CWM) plus placebo (high certainty).
3 findings from 1 review
RR 0.31 [0.1, 0.92]
1 study · 314 participants
High
RR 0.37 [0.19, 0.71]
1 study · 314 participants
High
RR 0.26 [0.18, 0.38]
2 studies · 432 participants
High
Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with restenosis after percutaneous coronary intervention in coronary heart disease
1 finding from 1 review
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) (high certainty).
1 finding from 1 review
Restenosis Coronary angiography · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower restenosis Coronary angiography compared with conventional western medicine (CWM) (high certainty).
1 finding from 1 review
Recurrence angina pectoris Treadmill exercise test · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) probably leads to lower recurrence angina pectoris Treadmill exercise test compared with conventional western medicine (CWM) (moderate certainty).
1 finding from 1 review
Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with restenosis after percutaneous coronary intervention in coronary heart disease
1 finding from 1 review
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) plus placebo (high certainty).
1 finding from 1 review
Overall survival · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of people with ≥ 1 serious adverse events · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease progression · participants with unresectable hepatocellular carcinoma
It is very uncertain whether E1B‐deleted (dl1520) adenovirus changes proportion of people with disease progression compared with percutaneous ethanol injection (very low certainty).
1 finding from 1 review
Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
It is very uncertain whether E1B‐deleted (dl1520) adenovirus changes adverse events considered non‐serious (number of participants) compared with percutaneous ethanol injection (very low certainty).
1 finding from 1 review
Intervention not reported
Enrolment · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
The intervention may leads to higher enrolment (low certainty).
1 finding from 1 review
Intervention not reported
Adherence · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
1 finding from 1 review
Intervention not reported
Completion · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
The intervention probably leads to higher completion (moderate certainty).
1 finding from 1 review